Cargando…
Commentary on “Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism”: A new role for plasminogen activator inhibitor‐1—An inhibitor of fibrinolysis predicts future venous thromboembolic events and links them to obesity
Autor principal: | Wojta, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328391/ https://www.ncbi.nlm.nih.gov/pubmed/35754015 http://dx.doi.org/10.1111/jth.15728 |
Ejemplares similares
-
Elevated plasma levels of plasminogen activator inhibitor‐1 are associated with risk of future incident venous thromboembolism
por: Frischmuth, Tobias, et al.
Publicado: (2022) -
Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022) -
Genetic association between plasminogen activator inhibitor‐1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta‐analysis
por: Huang, Guangbin, et al.
Publicado: (2019) -
Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty
por: Yukizawa, Yohei, et al.
Publicado: (2012) -
Commentary on “The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1”
por: von Meijenfeldt, Fien A.
Publicado: (2022)